Evogene Q3 EPS $(0.16) Up From $(0.19) YoY, Sales $97K Do Not Compare To $1.9M Estimate

Evogene (NYSE:EVGN) reported quarterly losses of $(0.16) per share. This is a 15.79 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $97 thousand

Benzinga · 11/13/2019 12:04

Evogene (NYSE:EVGN) reported quarterly losses of $(0.16) per share. This is a 15.79 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $97 thousand which missed the analyst consensus estimate of $1.9 million by 94.89 percent. This is a 73.57 percent decrease over sales of $367 thousand the same period last year.